RxElite, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RXEI research report →
About the company
RxElite, Inc. is a pharmaceutical company that specializes in the development, production, and commercialization of generic prescription drugs, particularly within specialty markets. Its diverse product portfolio encompasses Sterile Liquid Dose offerings, such as generic ophthalmic solutions (available in both unit-dose and multi-dose formats), sterile unit-dose respiratory inhalation products, and various injectable medications.
- CEO
- Richard Tener
- IPO
- 2020
- Employees
- 47
- HQ
- Meridian, ID, US
Price Chart
- Market Cap
- $1.48K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.58
- Div Yield
- 0.00%
- Gross Margin
- 5.12%
- Op Margin
- 436.80%
- Net Margin
- -610.52%
- ROE
- -273.67%
- ROIC
- 84.12%
- Revenue
- $2.81M · 138.97%
- Net Income
- $-17,165,275 · -18363.65%
- EPS
- $-0.27 · -3100.00%
- Op Income
- $12.28M
- FCF YoY
- -25487.88%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 6.40
- Avg Volume
- 134.452
Get TickerSpark's AI analysis on RXEI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 08 | RECTOR DAVID | other | 100,000 |
| Jun 4, 08 | RECTOR DAVID | other | 1,000,000 |
| Jun 4, 08 | RECTOR DAVID | sell | 400,000 |
| Jun 4, 08 | AUERBACH MARK | other | 100,000 |
| Jun 4, 08 | AUERBACH MARK | other | 1,000,000 |
| Jun 4, 08 | AUERBACH MARK | sell | 400,000 |
| Oct 11, 07 | RECTOR DAVID | other | 400,000 |
Our RXEI coverage
Recent articles, reports, and earnings notes.
No research on RXEI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RXEI report →Similar companies
Peers in the same neighborhood.